Brilinta Market: Overview
The increasing rates of heart attacks and strokes has highly increased the popularity of Brilinta in the medical industry. According to the World Health Organization, approximately 17 million people die of cardiovascular diseases every year. This alarming number calls for a need to deploy a robust preventive measure. Moreover, brilinta also eliminates the risk of infection-related death. A study called Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor (XANTHIPPE) displayed considerable improvement in the lung function of the pneumonia patients using brilinta.
The rising popularity of brilinta among the physicians and patients has encouraged Transparency Market Research to conduct an in-depth research on the global brilinta market. In its latest study, TMR offers a comprehensive analysis of the market’s structure and shed light on the key growth dynamics. It highlights the growth scenario and competitive landscape of the market. Moreover, it states business strategies deployed by the key enterprises functioning in the global brilinta market and ascertains the challenges faced by them in the long run.
Get a Glimpse of the In-depth Analysis through Our Brilinta Market Report Brochure
Brilinta Market: Notable Developments and Competitive Analysis
There are a very few players operating in the global brilinta market as the drug was approved a few years back. Listed below are a few notable developments in the market:
In June 2015, Sun Pharmaceutical Industries Ltd. collaborated with AstraZeneca Pharma India Limited (AZPIL), a leading manufacturer of brilinta. The agreement was aimed at enhancing the distribution network of “Axcer”, a new brand of ticagrelor drug. AZPIL already markets a ticagrelor drug under the trademark “Brilinta” in India. This collaboration helped Sun Pharmaceutical Industries to build a robust brand image by promoting the use of ticagrelor in India.
Brilinta Market: Key Drivers and Restraints
In recent times, there has been a steady rise in the development of ticagrelor drugs due to rising FDA approvals. Moreover, it has a greater efficacy as compared clopidogrel in the treatment of acute coronary syndrome. The results of the PLAT trial showed that patients treated with ticagrelor were less likely to die from stroke, vascular causes, and heart attack. These factors have highly contributed to expansion of the global brilinta market.
However, despite the numerous driving factors, there are a few restraints that may restrict the market’s growth. Side effects associated with ticagrelor use such as bleeding and dyspnea may discourage the use of ticagrelor. Nonetheless, development of new phararmaceutical compounds containing ticagrelor and rising awareness pertaining to the benefits of brilinta may propel the global brilinta market’s expansion.
Expanding Operations in Future? To Get the Perfect Launch Ask for a Custom Brilinta Market Report
Brilinta Market: Regional Analysis
Based on geography, the brilinta market is market is segmented into North America, Europe, China, and Japan. Out of these, North America is anticipated to dominate the global brilinta market due to increase in expenditure on healthcare facilities and rising geriatric population. The U.S. holds a major share in the market’s growth in this region due to rising cases of cardiovascular disorders. The market in Europe is also anticipated to grow at a promising pace due to rising patient population and recent progression in the economy. Furthermore, introduction of advanced treatment options and government initiatives have contributed to the brilinta market’s growth in this region. The market in China and Japan is anticipated to grow at a steady pace due to rising concerns regarding cardiovascular diseases and increasing research pertaining to the development of new drugs.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.